Tandem Diabetes Care Stock Forecast

Sell candidate since Jun 10, 2026 Gain 2.28%

The Tandem Diabetes Care stock price gained 5.06% on the last trading day (Friday, 12th Jun 2026), rising from $15.80 to $16.60. During the last trading day the stock fluctuated 7.16% from a day low at $15.51 to a day high of $16.62. The price has fallen in 7 of the last 10 days and is down by -3.49% for this period. Volume fell on the last day by -2 million shares and in total, 2 million shares were bought and sold for approximately $29.11 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -28.85% during the next 3 months and, with a 90% probability hold a price between $7.49 and $13.32 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

TNDM Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Tandem Diabetes Care stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $17.64 and $16.95. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, June 04, 2026, and so far it has fallen -14.65%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Tandem Diabetes Care stock

On the downside, the stock finds support just below today's level from accumulated volume at $15.48 and $13.53. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tandem Diabetes Care finds support just below today's level at $15.48. If this is broken, then the next support from accumulated volume will be at $13.53 and $12.82.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.11 between high and low, or 7.16%. For the last week, the stock has had daily average volatility of 7.90%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TNDM) For The Upcoming Trading Day Of Monday 15th

For the upcoming trading day on Monday, 15th we expect Tandem Diabetes Care to open at $16.24, and during the day (based on 14 day Average True Range), to move between $15.92 and $17.28, which gives a possible trading interval of +/-$1.36 (+/-8.52%) up or down from last closing price. If Tandem Diabetes Care takes out the full calculated possible swing range there will be an estimated 8.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $15.48 (6.75%) than the resistance at $18.03 (8.61%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Tandem Diabetes Care stock A Buy?

Tandem Diabetes Care holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.711 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 15, 2026 - $16.24 ( 2.15%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk